These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16353582)

  • 1. Baseline predictors of success when comparing two treatments.
    Roback PJ; Goldstein DJ; Rampey AH; Wilson MG
    Obes Res; 1994 Jul; 2(4):337-47. PubMed ID: 16353582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of long-term fluoxetine treatment of obesity--maximizing success.
    Goldstein DJ; Rampey AH; Roback PJ; Wilson MG; Hamilton SH; Sayler ME; Tollefson GD
    Obes Res; 1995 Nov; 3 Suppl 4():481S-490S. PubMed ID: 8697047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine: a randomized clinical trial in the maintenance of weight loss.
    Goldstein DJ; Rampey AH; Dornseif BE; Levine LR; Potvin JH; Fludzinski LA
    Obes Res; 1993 Mar; 1(2):92-8. PubMed ID: 16350565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fluoxetine and placebo in the treatment of obesity.
    Fernández-Soto ML; González-Jiménez A; Barredo-Acedo F; Luna del Castillo JD; Escobar-Jiménez F
    Ann Nutr Metab; 1995; 39(3):159-63. PubMed ID: 7486842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis.
    Norris SL; Zhang X; Avenell A; Gregg E; Schmid CH; Kim C; Lau J
    Arch Intern Med; 2004 Jul; 164(13):1395-404. PubMed ID: 15249348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating success of weight loss programs, with an application to fluoxetine weight reduction clinical trial data.
    Sayler ME; Goldstein DJ; Roback PJ; Atkinson RL
    Int J Obes Relat Metab Disord; 1994 Nov; 18(11):742-51. PubMed ID: 7866474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 12-month follow-up of fluoxetine and cognitive behavioral therapy for binge eating disorder.
    Grilo CM; Crosby RD; Wilson GT; Masheb RM
    J Consult Clin Psychol; 2012 Dec; 80(6):1108-13. PubMed ID: 22985205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants for smoking cessation.
    Hughes JR; Stead LF; Hartmann-Boyce J; Cahill K; Lancaster T
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD000031. PubMed ID: 24402784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interventions for the treatment of obesity in children and adolescents.
    Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.
    Whigham LD; Dhurandhar NV; Rahko PS; Atkinson RL
    Int J Obes (Lond); 2007 May; 31(5):850-7. PubMed ID: 17146452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder.
    Andersen SW; Clemow DB; Corya SA
    J Clin Psychiatry; 2005 Nov; 66(11):1468-76. PubMed ID: 16420086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT.
    Dennis M; Forbes J; Graham C; Hackett M; Hankey GJ; House A; Lewis S; Lundström E; Sandercock P; Mead G
    Health Technol Assess; 2020 May; 24(22):1-94. PubMed ID: 32452356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The addition of dexfenfluramine to fluoxetine in the treatment of obesity: a randomized clinical trial.
    Pedrinola F; Sztejnsznajd C; Lima N; Halpern A; Medeiros-Neto G
    Obes Res; 1996 Nov; 4(6):549-54. PubMed ID: 8946439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacotherapy for weight loss in patients with type 2 diabetes].
    Toubro S
    Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluoxetine versus other types of pharmacotherapy for depression.
    Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C
    Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder.
    Leombruni P; Pierò A; Lavagnino L; Brustolin A; Campisi S; Fassino S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1599-605. PubMed ID: 18598735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.